Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Thalidomide Following Surgery and IPHC for Colorectal/Appendiceal Cancer
NCT00310076Phase 2Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Oct 2002
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in colorectal cancer (CRC), appendiceal cancer, peritoneal carcinomatosis (PC), pseudomyxoma peritonei (PMP), sponsored by Wake Forest University Health Sciences. Started Oct 2002; status: completed.
02
Drugs
thalidomide
03
Conditions
colorectal cancer (CRC)appendiceal cancerperitoneal carcinomatosis (PC)pseudomyxoma peritonei (PMP)
Beyond the preview
Go deeper on NCT00310076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00310076.